John P. Butler Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

ZYNE Quotes by TradingView

John P. Butler is of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2023, when has been sold 80,765 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

John P. Butler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 10 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
80,765 Reduced 100.0%
0 Common Stock
Jun 14 2023
SELL
Open market or private sale
$40 $0.35 p/Share
115 Reduced 0.14%
80,765 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
47,824 Added 37.16%
80,880 Common Stock
Jun 14 2022
SELL
Open market or private sale
$54 $1.01 p/Share
53 Reduced 0.16%
33,056 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
23,109 Added 41.11%
33,109 Common Stock
Aug 03 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 33.33%
10,000 Common Stock

Also insider at

AKBA
Akebia Therapeutics, Inc. Healthcare
CEO and President
JPB

John P. Butler

Cambridge, MA

Track Institutional and Insider Activities on ZYNE

Follow Zynerba Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYNE shares.

Notify only if

Insider Trading

Get notified when an Zynerba Pharmaceuticals, Inc. insider buys or sells ZYNE shares.

Notify only if

News

Receive news related to Zynerba Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZYNE